Valantine Hannah
SEC Form 4 insider trading activity
Valantine Hannah has filed 6 SEC Form 4 filings (18 transaction rows) across 2 companies, including CDNA, BBIO, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.
On the most recent filing, Valantine Hannah is listed as Director at CareDx, Inc. Inside the rolling window, Valantine Hannah reported no open-market purchases and 7 open-market sales totaling $5.7M in CDNA and BBIO. The largest disclosed transaction in the window is a sale of 25,484 BBIO shares on Feb 27, 2026, worth $1.7M.
Companies traded
Other insiders at CDNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.7M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Valantine Hannah made?
Valantine Hannah has filed 6 SEC Form 4 filings (18 transaction rows) across 2 companies, including CDNA, BBIO since 2025.
Which companies does Valantine Hannah trade?
Valantine Hannah has filed SEC Form 4 disclosures for 2 companies, including CDNA, BBIO.
When was Valantine Hannah's most recent SEC Form 4 filing?
Valantine Hannah's most recent SEC Form 4 filing on Tracefour is dated Jul 17, 2026.
What is Valantine Hannah's total buy and sell value in the current window?
Inside the rolling retention window, Valantine Hannah bought $0 and sold $5.7M based on SEC Form 4 filings.
What was Valantine Hannah's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,484 BBIO shares on 2026-02-27, worth $1.7M, per SEC Form 4 filings.